FDA-Approved Treatments for Alzheimers FDA-Approved Drugs For Alzheimer's The FDA has approved medications that fall into two categories: drugs that change disease progression in people living with early Alzheimer's disease, and drugs that may temporarily mitigate some symptoms of Alzheimer's dementia
FDA Approves Treatment for Serious Liver Disease Known as . . . The U S Food and Drug Administration has approved Wegovy (semaglutide) injection to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis (excessive scar
New FDA Drug Approvals for 2026 - Drugs. com Up to date information on the latest FDA drug approvals Includes list of most recent approvals, the conditions approved for, and the approval history
6 Rare Diseases That Have New FDA-Approved Treatments Defined as diseases that affect fewer than 200,000 people in the U S , rare diseases collectively afflict about 350 million people worldwide, according to the National Organization for Rare Disorders An estimated 7,000 of these conditions have been identified, and more than 90% of them have no FDA-approved treatment
Medications for Treating ALS | The ALS Association Studies all over the world, many funded by The ALS Association, are ongoing to develop more treatments and a cure for ALS There are currently seven drugs approved by the U S Food and Drug Administration (FDA) to treat ALS and its symptoms: Qalsody, RELY
Otsuka wins FDA nod in ever-more-crowded kidney disease space A new FDA approval for a first-in-class drug has vaulted Otsuka into immunoglobulin A nephropathy (IgAN), an increasingly competitive kidney disease field targeted by multiple biopharma companies
Pulmonary Fibrosis Medications - American Lung Association Depending on the type of pulmonary fibrosis you have, there may be medicine available to treat your disease Only your medical provider can determine if these medications may be beneficial for you FDA-approved Drugs for IPF Currently, three drugs are FDA-approved for treatment of idiopathic pulmonary fibrosis (IPF), which is the most common form of PF These include nintedanib (Ofev
FDA approves Stanford Medicine-developed drug that treats . . . The U S Food and Drug Administration has approved a drug developed at Stanford Medicine that offers hope to people diagnosed with a rare cardiovascular disease, transthyretin amyloid cardiomyopathy, or ATTR-CM